John Cutrone - Profile and Investment Details

Investor Profile

John Cutrone is a Venture Capital, Corporate Venture Capital, Founder, Private Equity Firm based in United States with a diverse investment portfolio that includes companies such as GlobeImmune, Orchestra BioMed, Armada Water Assets, Motus GI, Helocyte, Outstanding Foods, Hydrofarm, Adgero Biopharmaceuticals, Deem, BackBeat Medical, SternAegis Ventures, Organovo Holdings, Kintara Therapeutics, Caliber Therapeutics, PROLOR Biotech, DarioHealth, InVivo Therapeutics, Corbus Pharmaceuticals, MATINAS BIOPHARMA, Aerami Therapeutics, . Over time, John Cutrone has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Cutrone is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Consumer Goods, Investment Management, Android, Energy, Wholesale, Cloud Computing, Diabetes, Finance, Software, Manufacturing, Biotechnology, Construction, Trust Estate Planning, Productivity Software, Nutrition, Food and Beverage, Groceries, Agriculture, Consulting, Utilities, Medical, Information Technology, B2B, Real Estate, Therapeutics, Financial Advisory, Digital Assets, Risk Management may find it worthwhile to explore potential connections with John Cutrone, as their portfolio suggests a familiarity and interest in this area.

Understanding John Cutrone’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.